Author Correction: Vorasidenib and ivosidenib in IDH1-mutant low-grade glioma: a randomized, perioperative phase 1 trial (Nature Medicine, (2023), 29, 3, (615-622), 10.1038/s41591-022-02141-2)

Ingo K. Mellinghoff; Min Lu; Patrick Y. Wen; Jennie W. Taylor; Elizabeth A. Maher; Isabel Arrillaga-Romany; Katherine B. Peters; Benjamin M. Ellingson; Marc K. Rosenblum; Saewon Chun; Kha Le; Ania Tassinari; Sung Choe; Youssef Toubouti; Steven Schoenfeld; Shuchi S. Pandya; Islam Hassan; Lori Steelman; Jennifer L. Clarke; Timothy F. Cloughesy

doi:10.1038/s41591-023-02473-7

Author Correction: Vorasidenib and ivosidenib in IDH1-mutant low-grade glioma: a randomized, perioperative phase 1 trial (Nature Medicine, (2023), 29, 3, (615-622), 10.1038/s41591-022-02141-2)

Ingo K. Mellinghoff, Min Lu, Patrick Y. Wen, Jennie W. Taylor, Elizabeth A. Maher, Isabel Arrillaga-Romany, Katherine B. Peters, Benjamin M. Ellingson, Marc K. Rosenblum, Saewon Chun, Kha Le, Ania Tassinari, Sung Choe, Youssef Toubouti, Steven Schoenfeld, Shuchi S. Pandya, Islam Hassan, Lori Steelman, Jennifer L. Clarke, Timothy F. Cloughesy

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

Correction to: Nature Medicine. Published online 23 February 2023.

Original language	English (US)
Pages (from-to)	302
Number of pages	1
Journal	Nature medicine
Volume	30
Issue number	1
DOIs	https://doi.org/10.1038/s41591-023-02473-7
State	Published - Jan 2024

ASJC Scopus subject areas

General Biochemistry, Genetics and Molecular Biology

Access to Document

10.1038/s41591-023-02473-7

Cite this

Mellinghoff, I. K., Lu, M., Wen, P. Y., Taylor, J. W., Maher, E. A., Arrillaga-Romany, I., Peters, K. B., Ellingson, B. M., Rosenblum, M. K., Chun, S., Le, K., Tassinari, A., Choe, S., Toubouti, Y., Schoenfeld, S., Pandya, S. S., Hassan, I., Steelman, L., Clarke, J. L., & Cloughesy, T. F. (2024). Author Correction: Vorasidenib and ivosidenib in IDH1-mutant low-grade glioma: a randomized, perioperative phase 1 trial (Nature Medicine, (2023), 29, 3, (615-622), 10.1038/s41591-022-02141-2). Nature medicine, 30(1), 302. https://doi.org/10.1038/s41591-023-02473-7

Author Correction: Vorasidenib and ivosidenib in IDH1-mutant low-grade glioma: a randomized, perioperative phase 1 trial (Nature Medicine, (2023), 29, 3, (615-622), 10.1038/s41591-022-02141-2). / Mellinghoff, Ingo K.; Lu, Min; Wen, Patrick Y. et al.
In: Nature medicine, Vol. 30, No. 1, 01.2024, p. 302.

Research output: Contribution to journal › Comment/debate › peer-review

Mellinghoff, IK, Lu, M, Wen, PY, Taylor, JW, Maher, EA, Arrillaga-Romany, I, Peters, KB, Ellingson, BM, Rosenblum, MK, Chun, S, Le, K, Tassinari, A, Choe, S, Toubouti, Y, Schoenfeld, S, Pandya, SS, Hassan, I, Steelman, L, Clarke, JL & Cloughesy, TF 2024, 'Author Correction: Vorasidenib and ivosidenib in IDH1-mutant low-grade glioma: a randomized, perioperative phase 1 trial (Nature Medicine, (2023), 29, 3, (615-622), 10.1038/s41591-022-02141-2)', Nature medicine, vol. 30, no. 1, pp. 302. https://doi.org/10.1038/s41591-023-02473-7

@article{518cb57a5eb94eec8b69a5493554cadd,

title = "Author Correction: Vorasidenib and ivosidenib in IDH1-mutant low-grade glioma: a randomized, perioperative phase 1 trial (Nature Medicine, (2023), 29, 3, (615-622), 10.1038/s41591-022-02141-2)",

abstract = "Correction to: Nature Medicine. Published online 23 February 2023.",

author = "Mellinghoff, {Ingo K.} and Min Lu and Wen, {Patrick Y.} and Taylor, {Jennie W.} and Maher, {Elizabeth A.} and Isabel Arrillaga-Romany and Peters, {Katherine B.} and Ellingson, {Benjamin M.} and Rosenblum, {Marc K.} and Saewon Chun and Kha Le and Ania Tassinari and Sung Choe and Youssef Toubouti and Steven Schoenfeld and Pandya, {Shuchi S.} and Islam Hassan and Lori Steelman and Clarke, {Jennifer L.} and Cloughesy, {Timothy F.}",

note = "Publisher Copyright: {\textcopyright} 2023, The Author(s).",

year = "2024",

month = jan,

doi = "10.1038/s41591-023-02473-7",

language = "English (US)",

volume = "30",

pages = "302",

journal = "Nature medicine",

issn = "1078-8956",

publisher = "Nature Publishing Group",

number = "1",

}

TY - JOUR

T1 - Author Correction

T2 - Vorasidenib and ivosidenib in IDH1-mutant low-grade glioma: a randomized, perioperative phase 1 trial (Nature Medicine, (2023), 29, 3, (615-622), 10.1038/s41591-022-02141-2)

AU - Mellinghoff, Ingo K.

AU - Lu, Min

AU - Wen, Patrick Y.

AU - Taylor, Jennie W.

AU - Maher, Elizabeth A.

AU - Arrillaga-Romany, Isabel

AU - Peters, Katherine B.

AU - Ellingson, Benjamin M.

AU - Rosenblum, Marc K.

AU - Chun, Saewon

AU - Le, Kha

AU - Tassinari, Ania

AU - Choe, Sung

AU - Toubouti, Youssef

AU - Schoenfeld, Steven

AU - Pandya, Shuchi S.

AU - Hassan, Islam

AU - Steelman, Lori

AU - Clarke, Jennifer L.

AU - Cloughesy, Timothy F.

PY - 2024/1

Y1 - 2024/1

N2 - Correction to: Nature Medicine. Published online 23 February 2023.

AB - Correction to: Nature Medicine. Published online 23 February 2023.

UR - http://www.scopus.com/inward/record.url?scp=85163728507&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85163728507&partnerID=8YFLogxK

U2 - 10.1038/s41591-023-02473-7

DO - 10.1038/s41591-023-02473-7

M3 - Comment/debate

C2 - 37400643

AN - SCOPUS:85163728507

SN - 1078-8956

VL - 30

SP - 302

JO - Nature medicine

JF - Nature medicine

IS - 1

ER -

Author Correction: Vorasidenib and ivosidenib in IDH1-mutant low-grade glioma: a randomized, perioperative phase 1 trial (Nature Medicine, (2023), 29, 3, (615-622), 10.1038/s41591-022-02141-2)

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this